Production (Stage)
InspireMD, Inc.
NSPR
$2.53
$0.2510.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.53M | 1.95M | 1.81M | 1.74M | 1.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.53M | 1.95M | 1.81M | 1.74M | 1.51M |
| Cost of Revenue | 1.24M | 1.48M | 1.40M | 1.41M | 1.22M |
| Gross Profit | 292.00K | 469.00K | 414.00K | 331.00K | 292.00K |
| SG&A Expenses | 7.69M | 6.14M | 4.96M | 5.19M | 5.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.99M | 11.32M | 10.27M | 10.00M | 8.93M |
| Operating Income | -11.46M | -9.37M | -8.46M | -8.26M | -7.41M |
| Income Before Tax | -11.17M | -9.12M | -7.89M | -7.91M | -7.03M |
| Income Tax Expenses | -- | 59.00K | -- | -- | -- |
| Earnings from Continuing Operations | -11.17M | -9.17M | -7.89M | -7.91M | -7.03M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.17M | -9.17M | -7.89M | -7.91M | -7.03M |
| EBIT | -11.46M | -9.37M | -8.46M | -8.26M | -7.41M |
| EBITDA | -11.36M | -9.29M | -8.39M | -8.19M | -7.35M |
| EPS Basic | -0.22 | -0.19 | -0.16 | -0.22 | -0.21 |
| Normalized Basic EPS | -0.14 | -0.11 | -0.10 | -0.14 | -0.13 |
| EPS Diluted | -0.22 | -0.19 | -0.16 | -0.22 | -0.21 |
| Normalized Diluted EPS | -0.14 | -0.11 | -0.10 | -0.14 | -0.13 |
| Average Basic Shares Outstanding | 49.99M | 48.89M | 48.37M | 35.88M | 34.24M |
| Average Diluted Shares Outstanding | 49.99M | 48.89M | 48.37M | 35.88M | 34.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |